Packer, Milton http://orcid.org/0000-0003-1828-2387
Article History
First Online: 13 July 2023
Competing interests
: In the past three years, M.P. has been a consultant to 89bio, Abbvie, Altimmune, Amgen, Ardelyx, AstraZeneca, Boehringer Ingelheim, Caladrius, Casana, CSL Behring, Cytokinetics, Imara, Lilly, Moderna, Novartis, Pharmacosmos, Reata, Regeneron, Relypsa and Salamandra.